vs
Side-by-side financial comparison of Axil Brands, Inc. (AXIL) and Sensus Healthcare, Inc. (SRTS). Click either name above to swap in a different company.
Axil Brands, Inc. is the larger business by last-quarter revenue ($8.1M vs $4.9M, roughly 1.6× Sensus Healthcare, Inc.). Axil Brands, Inc. runs the higher net margin — 8.7% vs -64.1%, a 72.8% gap on every dollar of revenue. On growth, Axil Brands, Inc. posted the faster year-over-year revenue change (5.2% vs -62.2%). Axil Brands, Inc. produced more free cash flow last quarter ($906.4K vs $-2.4M). Over the past eight quarters, Axil Brands, Inc.'s revenue compounded faster (12.1% CAGR vs -31.9%).
Axil Brands, Inc. is a U.S.-headquartered company that designs, manufactures and markets premium hearing protection products, audio enhancement devices and personal audio accessories. Its offerings include custom-fit earplugs, Bluetooth-enabled hearing buds for work, sports and leisure use, serving both consumer and professional segments across global markets.
Sensus Healthcare, Inc. is a medical technology company that designs, manufactures and commercializes innovative non-invasive superficial radiation therapy systems. Its products are primarily used for treating non-melanoma skin cancers, keloids, and select cosmetic dermatology conditions, serving healthcare providers and clinical facilities worldwide.
AXIL vs SRTS — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $8.1M | $4.9M |
| Net Profit | $704.9K | $-3.2M |
| Gross Margin | 68.1% | 38.4% |
| Operating Margin | 11.1% | -63.8% |
| Net Margin | 8.7% | -64.1% |
| Revenue YoY | 5.2% | -62.2% |
| Net Profit YoY | 11.2% | -304.9% |
| EPS (diluted) | $0.09 | $-0.19 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $8.1M | $4.9M | ||
| Q3 25 | $6.9M | $6.9M | ||
| Q2 25 | $5.8M | $7.3M | ||
| Q1 25 | $6.9M | $8.3M | ||
| Q4 24 | $7.7M | $13.1M | ||
| Q3 24 | $5.9M | $8.8M | ||
| Q2 24 | $6.5M | $9.2M | ||
| Q1 24 | $6.5M | $10.7M |
| Q4 25 | $704.9K | $-3.2M | ||
| Q3 25 | $334.3K | $-943.0K | ||
| Q2 25 | $-245.6K | $-1.0M | ||
| Q1 25 | $576.7K | $-2.6M | ||
| Q4 24 | $633.7K | $1.5M | ||
| Q3 24 | $-109.8K | $1.2M | ||
| Q2 24 | $49.5K | $1.6M | ||
| Q1 24 | $781.1K | $2.3M |
| Q4 25 | 68.1% | 38.4% | ||
| Q3 25 | 67.6% | 39.4% | ||
| Q2 25 | 70.0% | 39.7% | ||
| Q1 25 | 71.7% | 52.2% | ||
| Q4 24 | 71.1% | 54.4% | ||
| Q3 24 | 71.0% | 59.3% | ||
| Q2 24 | 71.5% | 58.7% | ||
| Q1 24 | 71.5% | 62.5% |
| Q4 25 | 11.1% | -63.8% | ||
| Q3 25 | 6.0% | -37.3% | ||
| Q2 25 | 0.8% | -26.6% | ||
| Q1 25 | 8.4% | -31.7% | ||
| Q4 24 | 8.7% | 13.2% | ||
| Q3 24 | -2.4% | 16.9% | ||
| Q2 24 | 2.6% | 21.5% | ||
| Q1 24 | -1.6% | 27.1% |
| Q4 25 | 8.7% | -64.1% | ||
| Q3 25 | 4.9% | -13.7% | ||
| Q2 25 | -4.3% | -14.2% | ||
| Q1 25 | 8.3% | -30.8% | ||
| Q4 24 | 8.2% | 11.8% | ||
| Q3 24 | -1.9% | 13.7% | ||
| Q2 24 | 0.8% | 17.4% | ||
| Q1 24 | 12.1% | 21.3% |
| Q4 25 | $0.09 | $-0.19 | ||
| Q3 25 | $0.04 | $-0.06 | ||
| Q2 25 | $-0.03 | $-0.06 | ||
| Q1 25 | $0.07 | $-0.16 | ||
| Q4 24 | $0.08 | $0.10 | ||
| Q3 24 | $-0.02 | $0.07 | ||
| Q2 24 | $0.11 | $0.10 | ||
| Q1 24 | $0.04 | $0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.0M | $22.1M |
| Total DebtLower is stronger | $138.3K | — |
| Stockholders' EquityBook value | $11.1M | $48.1M |
| Total Assets | $16.2M | $53.0M |
| Debt / EquityLower = less leverage | 0.01× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.0M | $22.1M | ||
| Q3 25 | $4.1M | $24.5M | ||
| Q2 25 | $4.8M | $22.2M | ||
| Q1 25 | $4.7M | $19.1M | ||
| Q4 24 | $5.2M | $22.1M | ||
| Q3 24 | $4.1M | $22.6M | ||
| Q2 24 | $3.3M | $19.0M | ||
| Q1 24 | $4.9M | $14.7M |
| Q4 25 | $138.3K | — | ||
| Q3 25 | $139.2K | — | ||
| Q2 25 | $140.2K | — | ||
| Q1 25 | $141.0K | — | ||
| Q4 24 | $143.3K | — | ||
| Q3 24 | $144.3K | — | ||
| Q2 24 | $146.6K | — | ||
| Q1 24 | — | — |
| Q4 25 | $11.1M | $48.1M | ||
| Q3 25 | $10.2M | $51.2M | ||
| Q2 25 | $9.7M | $52.1M | ||
| Q1 25 | $9.7M | $53.0M | ||
| Q4 24 | $8.8M | $55.8M | ||
| Q3 24 | $7.9M | $54.1M | ||
| Q2 24 | $7.7M | $52.9M | ||
| Q1 24 | $8.8M | $51.2M |
| Q4 25 | $16.2M | $53.0M | ||
| Q3 25 | $15.4M | $58.3M | ||
| Q2 25 | $12.9M | $58.9M | ||
| Q1 25 | $13.0M | $60.2M | ||
| Q4 24 | $13.7M | $62.2M | ||
| Q3 24 | $11.4M | $59.9M | ||
| Q2 24 | $11.0M | $58.2M | ||
| Q1 24 | $12.7M | $57.3M |
| Q4 25 | 0.01× | — | ||
| Q3 25 | 0.01× | — | ||
| Q2 25 | 0.01× | — | ||
| Q1 25 | 0.01× | — | ||
| Q4 24 | 0.02× | — | ||
| Q3 24 | 0.02× | — | ||
| Q2 24 | 0.02× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $934.8K | $-2.2M |
| Free Cash FlowOCF − Capex | $906.4K | $-2.4M |
| FCF MarginFCF / Revenue | 11.1% | -47.9% |
| Capex IntensityCapex / Revenue | 0.3% | 3.2% |
| Cash ConversionOCF / Net Profit | 1.33× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $332.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $934.8K | $-2.2M | ||
| Q3 25 | $-739.2K | $2.3M | ||
| Q2 25 | $194.4K | $3.1M | ||
| Q1 25 | $-169.9K | $-2.7M | ||
| Q4 24 | $1.0M | $-827.0K | ||
| Q3 24 | $897.3K | $4.0M | ||
| Q2 24 | $-336.6K | $4.2M | ||
| Q1 24 | $-912.8K | $-8.2M |
| Q4 25 | $906.4K | $-2.4M | ||
| Q3 25 | $-747.6K | $2.3M | ||
| Q2 25 | — | $3.1M | ||
| Q1 25 | $-258.2K | $-2.7M | ||
| Q4 24 | $941.1K | $-1.1M | ||
| Q3 24 | — | $3.6M | ||
| Q2 24 | $-394.9K | $4.2M | ||
| Q1 24 | $-922.1K | $-8.4M |
| Q4 25 | 11.1% | -47.9% | ||
| Q3 25 | -10.9% | 33.3% | ||
| Q2 25 | — | 42.2% | ||
| Q1 25 | -3.7% | -32.2% | ||
| Q4 24 | 12.2% | -8.6% | ||
| Q3 24 | — | 40.9% | ||
| Q2 24 | -6.1% | 45.8% | ||
| Q1 24 | -14.3% | -79.0% |
| Q4 25 | 0.3% | 3.2% | ||
| Q3 25 | 0.1% | 0.1% | ||
| Q2 25 | — | 0.4% | ||
| Q1 25 | 1.3% | 0.1% | ||
| Q4 24 | 0.9% | 2.3% | ||
| Q3 24 | — | 3.8% | ||
| Q2 24 | 0.9% | 0.0% | ||
| Q1 24 | 0.1% | 2.2% |
| Q4 25 | 1.33× | — | ||
| Q3 25 | -2.21× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -0.29× | — | ||
| Q4 24 | 1.59× | -0.53× | ||
| Q3 24 | — | 3.25× | ||
| Q2 24 | -6.80× | 2.62× | ||
| Q1 24 | -1.17× | -3.60× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXIL
| Hearing Enhancement And Protection | $7.8M | 95% |
| Other | $378.9K | 5% |
SRTS
| Products | $2.8M | 57% |
| Other | $2.1M | 43% |
